BA
PACB icon

BlackRock Advisors’s Pacific Biosciences PACB Stock Holding History

BlackRock Advisors’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$6.43M Buy
1,691,107
+7,087
+0.4% +$51.5K 0.01% 1046
2016
Q3 		$15.1M Sell
1,684,020
-1,314
-0.1% -$11K 0.02% 661
2016
Q2 		$11.9M Buy
1,685,334
+99,697
+6% +$911K 0.01% 764
2016
Q1 		$13.5M Buy
1,585,637
+78,220
+5% +$769K 0.01% 677
2015
Q4 		$19.8M Sell
1,507,417
-51,335
-3% -$461K 0.02% 547
2015
Q3 		$5.71M Sell
1,558,752
-768,264
-33% -$3.76M 0.01% 1039
2015
Q2 		$13.4M Sell
2,327,016
-459,008
-16% -$2.66M 0.01% 666
2015
Q1 		$16.3M Sell
2,786,024
-373,193
-12% -$2.57M 0.02% 631
2014
Q4 		$24.8M Buy
3,159,217
+95,227
+3% +$609K 0.02% 492
2014
Q3 		$15M Buy
3,063,990
+120,845
+4% +$632K 0.02% 652
2014
Q2 		$18.2M Buy
2,943,145
+281,929
+11% +$1.41M 0.02% 589
2014
Q1 		$14.2M Buy
2,661,216
+534,141
+25% +$3.38M 0.01% 663
2013
Q4 		$11.1M Buy
2,127,075
+1,416,914
+200% +$6.51M 0.01% 760
2013
Q3 		$3.92M Buy
710,161
+4,145
+0.6% +$14.4K ﹤0.01% 1023
2013
Q2 		$1.79M Buy
+706,016
New +$1.76M ﹤0.01% 1152

Other funds holding PACB

MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BlackRock Advisors's PACB Position: Q4 2016 in Review

BlackRock Advisors increased its Pacific Biosciences (PACB) stake by 0.42% in Q4 2016, buying an estimated $51.5K and bringing the position to 1,691,107 shares worth $6.43M. The position accounts for 0.01% of the portfolio, ranked #1046.

BlackRock Advisors first reported a position in PACB in Q2 2013 and has held it in 15 quarters since. The position peaked at $24.8M in Q4 2014. 115 funds tracked by Wall St. Rank hold PACB as of Q4 2016.

  • BlackRock Advisors held 1,691,107 shares of Pacific Biosciences worth $6.43M as of Q4 2016.
  • BlackRock Advisors bought 7,087 Pacific Biosciences shares in Q4 2016, an estimated $51.5K.
  • Pacific Biosciences made up 0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1046 holding.
  • BlackRock Advisors first reported a position in Pacific Biosciences in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Pacific Biosciences position peaked at $24.8M in Q4 2014.
  • 115 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.